C0282574||EpiDerm™
C1511123||3D human reconstructed skin micronucleus (RSMN) assay
C3850080||Historical control
C0565962||proof
C2603343||principle studies
C1510438||mechanistic assay
C1511123||in vitro human reconstructed skin micronucleus (RSMN) assay
C0282574||EpiDerm™
C0003059||animal alternative
C0220806||chemicals
C0456611||cosmetic ingredients
C1515655||in vivo
C1510438||assays
C0392366||test
C0220905||regulatory
C0011109||decision-making
C1511123||RSMN assay
C0022877||laboratory
C2983608||Good Laboratory Practice
C3850013||OECD
C0162791||test guideline 487
C1512977||mammalian cell
C0026006||micronucleus test
C1510438||assay
C0026879||direct-acting genotoxins
C0026879||genotoxins
C0025519||metabolism
C0243095||non-genotoxic
C0243095||non-carcinogenic
C0220806||chemicals
C0684224||report
C0936012||analysis
C3850080||historical control
C4048301||micronuclei
C0333909||binucleated cells
C0037638||solvents
C0040808||treatment regimens
C2698671||mechanistic studies
C0242481||CREST analysis
C1510438||RSMN assay
C0949641||aneugens
C0008904||clastogens
C1510438||assay
C0079189||cytokines
C0334094||proliferative
C0600688||toxic effects
C0220806||chemicals